The glucocorticoid receptor gene, longevity, and the complex disorders of Western societies

American Journal of Medicine

Volumn 117, Issue 3, 2004, Pages 204-207

  Chrousos, George P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID;

ADDISON DISEASE; CUSHING SYNDROME; DNA POLYMORPHISM; EDITORIAL; GENETIC VARIABILITY; HUMAN; HYPERSENSITIVITY; LONGEVITY; METABOLIC DISORDER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; GENETICS; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PHYSIOLOGY;

GLUCOCORTICOIDS; HUMANS; LONGEVITY; METABOLIC SYNDROME X; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 3843071883     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.05.006     Document Type: Editorial

References (20)

1. th ed 2001 McGraw-Hill New York, New York 609 632
2. G.P. Chrousos Stressors, stress and neuroendocrine integration of the adaptive response The 1997 Hans Selye Memorial Lecture Ann NY Acad Sci 851 1998 311 335
3. D. Franchimont, T. Kino, J. Galon, G.U. Meduri, G.P. Chrousos Glucocorticoids and inflammation revisited. The state-of-the-art. NIH Clinical Staff Conference NeuroImmunoModulation 10 2003 247 260
4. J. Galon, D. Franchimont, N Hiroi Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells FASEB J 16 2002 61 71
5. van Rossum EFC, Feelders RA, van den Beld AW, et al. Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men. Am J Med. 2004;117:158-162.
6. E.F. van Rossum, J.W. Koper, N.A Huizenga A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels Diabetes 51 2002 3128 3134
7. S. Wuest, E. van Rossum, I. Federenko, J. Koper, R. Kumsta, D. Hellhammer Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress J Clin Endocrinol Metab 89 2004 565 573
8. G.P. Chrousos, E. Charmandari, T. Kino Glucocorticoid action networksAn introduction to systems biology J Clin Endocrinol Metab 89 2004 563 564
9. C.M. Bamberger, H.M. Schulte, G.P. Chrousos Molecular determinants of glucocorticoid receptor function and tissue sensitivity Endo Rev 17 1996 221 244
10. T. Kino, M.U. De Martino, E. Charmandari, M. Mirani, G.P. Chrousos Tissue glucocorticoid resistance/hypersensitivity syndromes J Steroid Biochem Mol Biol 85 2003 457 467
11. th ed 2001 McGraw-Hill New York, New York 387 524
12. G.P. Chrousos, S. Detera-Wadleigh, M. Karl Syndromes of glucocorticoid resistance. NIH Clinical Staff Conference Ann Int Med 119 1993 1113 1124
13. T.C. Friedman, G. Mastorakos, T.D. Newman Carbohydrate and lipid metabolism in endogenous hypercortisolism shared features with metabolic syndrome X and noninsulin-dependent diabetes mellitus Endocr J 43 1996 645 656
14. G.P. Chrousos The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome Neuro-endocrine and target tissue-related causes Intern J Obesity 24 2000 S50 S55
15. D.I.W. Phillips, D.J.P. Barker, C.H.D Fall Elevated plasma cortisol concentrations A link between low birth weight and the insulin resistance syndrome J Clin Endocrinol Metab 83 1998 757 760
16. B. McEwen Protecting and damaging effects of stress mediators N Engl J Med 338 1999 171 179
17. G.P. Chrousos The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation N Eng J Med 332 1995 1351 1362
18. D.A. Papanicolaou, R.L. Wilder, S.C. Manolagas, G.P. Chrousos The pathophysiologic roles of interleukin-6 in humans Ann Intern Med 128 1998 127 137
19. P.W. Gold, G.P. Chrousos Organization of the stress system and its dysregulation in melancholic and atypical depression High vs. low CRH/NE states Mol Psychiatry 7 2002 254 275
20. D.J. Clauw, G.P. Chrousos Chronic pain and fatigue syndromes overlapping clinical and neuroendocrine features and potential pathogenic mechanisms Neuroimmunomodulation 4 1997 134 153